Agilent Technologies, Inc. (NYSE:A) was the target of a significant decrease in short interest in September. As of September 29th, there was short interest totalling 2,227,391 shares, a decrease of 38.2% from the September 15th total of 3,601,536 shares. Approximately 0.7% of the company’s stock are short sold. Based on an average trading volume of 1,368,580 shares, the short-interest ratio is currently 1.6 days.

In other Agilent Technologies news, insider Dominique Grau sold 13,007 shares of the stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $62.00, for a total value of $806,434.00. Following the transaction, the insider now owns 60,098 shares in the company, valued at $3,726,076. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Mark Doak sold 12,421 shares of the stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $61.57, for a total value of $764,760.97. The disclosure for this sale can be found here. In the last quarter, insiders sold 165,720 shares of company stock worth $10,488,739.

Institutional investors and hedge funds have recently made changes to their positions in the business. Balentine LLC raised its stake in Agilent Technologies by 2.9% during the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock valued at $106,000 after buying an additional 50 shares during the last quarter. Sun Life Financial INC raised its stake in Agilent Technologies by 26,144.4% during the 2nd quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock valued at $140,000 after buying an additional 2,353 shares during the last quarter. Acrospire Investment Management LLC raised its stake in Agilent Technologies by 92.3% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock valued at $148,000 after buying an additional 1,200 shares during the last quarter. Parallel Advisors LLC raised its stake in Agilent Technologies by 5.3% during the 2nd quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock valued at $157,000 after buying an additional 131 shares during the last quarter. Finally, Trust Co. of Vermont raised its stake in Agilent Technologies by 1.8% during the 2nd quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock valued at $166,000 after buying an additional 50 shares during the last quarter.

Shares of Agilent Technologies (NYSE A) opened at 66.12 on Wednesday. Agilent Technologies has a 52-week low of $42.92 and a 52-week high of $67.82. The firm has a 50-day moving average price of $65.36 and a 200-day moving average price of $60.01. The stock has a market capitalization of $21.27 billion, a P/E ratio of 47.23 and a beta of 1.30.

Agilent Technologies (NYSE:A) last announced its earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.49 EPS. On average, analysts predict that Agilent Technologies will post $2.32 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 25th. Shareholders of record on Tuesday, October 3rd will be paid a dividend of $0.132 per share. The ex-dividend date is Monday, October 2nd. This represents a $0.53 dividend on an annualized basis and a yield of 0.80%. Agilent Technologies’s dividend payout ratio is presently 27.32%.

Several analysts have recently commented on A shares. BidaskClub downgraded Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 12th. Jefferies Group LLC reissued a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a research note on Wednesday, August 9th. Deutsche Bank AG reissued a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a research note on Thursday, June 22nd. Barclays PLC reissued a “buy” rating and issued a $67.00 price objective on shares of Agilent Technologies in a research note on Wednesday, July 19th. Finally, Janney Montgomery Scott increased their price objective on Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, August 16th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $65.12.

ILLEGAL ACTIVITY WARNING: “Short Interest in Agilent Technologies, Inc. (A) Drops By 38.2%” was published by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was copied illegally and republished in violation of United States and international trademark & copyright law. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/10/18/short-interest-in-agilent-technologies-inc-a-drops-by-38-2.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.